Page last updated: 2024-12-06

amafolone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

amafolone: RN given refers to parent cpd; NM refers to HCl [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID40112
CHEMBL ID2106671
SCHEMBL ID11011740
MeSH IDM0055465

Synonyms (20)

Synonym
amafolone
(2s,3s,5s,8r,9s,10s,13s,14s)-3-amino-2-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one
50588-47-1
CHEMBL2106671
3alpha-amino-2beta-hydroxy-5alpha-androstan-17-on
amafolonum [inn-latin]
amafolona
amafolone [inn:ban]
unii-n8y78okp8d
amafolonum
n8y78okp8d ,
amafolona [inn-spanish]
3alpha-amino-2beta-hydroxy-5alpha-androstan-17-one
(2beta,3alpha,5alpha)-3-amino-2-hydroxyandrostan-17-one, hydrochloride
3.alpha.-amino-2.beta.-hydroxy-5.alpha.-androstan-17-one
amafolone [inn]
SCHEMBL11011740
DTXSID90198607
Q27284718
AKOS040750385

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Unlike Org 6001, quinidine failed to produce a shift in calcium log dose-response curves in driven depolarized preparations and induced positive inotropy in the presence of functional sodium channels."( Effects of selective channel blocking agents on contractions and action potentials in K+-depolarized guinea-pig atria.
Brown, J; Marshall, RJ; Winslow, E, 1985
)
0.27
" 3 On a dosage basis, encainide was seven times, lorcainide fourteen times and ORG 6001 twice as potent as lignocaine in raising VFT."( Antifibrillatory efficacy of encainide, loracainide and ORG 6001 compared with lignocaine in isolated hearts of rabbits and guinea-pigs.
Almotrefi, AA; Baker, JB, 1981
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (95.65)18.7374
1990's1 (4.35)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (8.33%)5.53%
Reviews1 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]